Breast Neoplasms: all 12,820 studies
Page 100 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Breast Cancer Long-term Outcome of Cardiac DysfunctionCompletedNCT01904331
- Study of AeroForm Tissue Expander for Breast ReconstructionCompletedNCT01903174Not applicable
- Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyActive, not recruitingNCT01901094Phase 3
- A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature AssayCompletedNCT01899079
- Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast CancerActive, not recruitingNCT01898117Phase 2
- Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With CancerCompletedNCT01896778Not applicable
- Safety Study of VM206RY in Subjects With Expression of HER2 in Breast CancerCompletedNCT01895491Phase 1
- Real World Efficiency of Trastuzumab in Early Breast CancerCompletedNCT01894711
- Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative ChemotherapyCompletedNCT01894451Early Phase 1
- Effects of Electrical Stimulation on Blood Circulation and Sensibility Tactil in LymphadenectomyStatus unknownNCT01893957Not applicable
- Applicability of Video Games and Vibrational Therapy in Reducing Pain Secondary to Breast CancerCompletedNCT01893944Not applicable
- Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast CancerCompletedNCT01891227Phase 2
- Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing StrategyStatus unknownNCT01891123Not applicable
- Fat Metabolism Following Chemotherapy in Breast CancerTerminatedNCT01890824
- The Effects of Circadian Gene on Sleep and Associated Symptoms in Breast Cancer Patients Under ChemotherapyCompletedNCT01887925
- Study to Demonstrate the Preliminary Safety and Effectiveness of IPBS in Performing MRI-Guided Targeting and Intervention of Breast Tissue in Female Patients Indicated for MRI-Guided Breast BiopsyCompletedNCT01885741Not applicable
- Breast Tissue Study of Breast Diseases Among Women in Hong KongCompletedNCT01885039
- Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer PatientsCompletedNCT01885013Phase 2
- AZD8186 First Time In Patient Ascending Dose StudyCompletedNCT01884285Phase 1
- Value of Tomosynthesis in Breast Lesion Characterization and Breast Cancer StagingTerminatedNCT01881880Not applicable
- Window of Opportunity Study Targeting the Inflammatory MilieuCompletedNCT01881048Early Phase 1
- An Internet-based Psychosexual Intervention for Couples Following Treatment for Breast CancerCompletedNCT01881022Not applicable
- Ultrasound and Mammography for Screening Breast Cancer in Chinese WomenCompletedNCT01880853Not applicable
- Selective Image Guided Resection of Axillary Lymph NodesCompletedNCT01880645Not applicable
- Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast CancerStatus unknownNCT01880385Phase 1
- PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer RiskCompletedNCT01879189Not applicable
- Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast CancerCompletedNCT01878695Phase 1
- Feasibility of a Team Approach for Discussing Prognosis and Treatment Goals in Breast CancerCompletedNCT01876238Not applicable
- Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + LapatinibCompletedNCT01875666Early Phase 1
- Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPICompletedNCT01874522Phase 1
- Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast CancerCompletedNCT01874184Not applicable
- Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and SurgeryActive, not recruitingNCT01872975Not applicable
- Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast CancerActive, not recruitingNCT01872260Phase 1/2
- POWER-remote Weight Loss Program in Early Stage Breast CancerCompletedNCT01871116Not applicable
- Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid TumorsCompletedNCT01867879Phase 1
- Breast Cancer and Chemo-amennorheaCompletedNCT01867229
- Internet-Delivered Cognitive Training For Breast Cancer Survivors With Cognitive ComplaintsCompletedNCT01866813Not applicable
- Effect of the Nursing Intervention "Spiritual Support"Status unknownNCT01866670Phase 2
- Using National University Cancer Institute of Singapore (NCIS) Registry to Measure Time Trends in Quality of Care for Breast Cancer Patients in a National Cancer CentreStatus unknownNCT01866631
- Study of Circulating and Tumor Biomarkers in Breast Cancer PatientsStatus unknownNCT01866202
- A Study to Evaluate Denosumab in Young Patients With Primary Breast CancerTerminatedNCT01864798Phase 2
- FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer PatientsCompletedNCT01864083Early Phase 1
- Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic LesionsCompletedNCT01862900Phase 1
- A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung CancerCompletedNCT01862081Phase 1
- BP-C1 in Metastatic Breast Cancer PatientsCompletedNCT01861509Phase 1
- Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary TreatmentCompletedNCT01859936Phase 4
- PET Study of Breast Cancer Patients Using [68Ga]ABY-025CompletedNCT01858116Phase 1/2
- Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast CancerCompletedNCT01857193Phase 1
- Comparison Study of Sentinel Lymph Node Biopsy by Multimodal Method in Breast CancerCompletedNCT01856452Phase 2
- Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast CancersTerminatedNCT01856036Not applicable
- Breast Cancer Molecular Analysis ProtocolCompletedNCT01855503
- Impact of ADM in Reduction of Surgical Complexity of Breast Reconstructions With Implants (Nava)TerminatedNCT01853436Not applicable
- Enhancing Exercise in Breast Cancer SurvivorsCompletedNCT01849978Not applicable
- Assessment of Ability of Breath Hold for Left-sided Breast Cancer Radiation Therapy to Reduce Side Effects to HeartCompletedNCT01849614
- Neoadjuvant ECS Versus ECF in Local Advanced Breast CancerStatus unknownNCT01849380Phase 4
- Testing Spectrosense EVA System for Detection of Breast Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled AirStatus unknownNCT01849328
- Randomized Trial on Intraoperative Radiotherapy Full Dose Vs External RadiotherapyCompletedNCT01849133Not applicable
- Paclitaxol Every 2 Week Versus Paclitaxol Every 1 Week in the Adjuvant Treatment of Breast CancerStatus unknownNCT01848197Not applicable
- A Bioequivalence Study of Capecitabine TabletsCompletedNCT01846650Phase 1
- Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast CancerCompletedNCT01846091Phase 1
- Step by Step: A Tailored Walking Intervention for Breast Cancer SurvivorsCompletedNCT01845519Not applicable
- Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast CancersCompletedNCT01843725Phase 1
- Effect of Combined Exercise Post-treatment Intervention in Lean Mass Recovery in Breast Cancer Survival.Status unknownNCT01843608Not applicable
- Abiraterone Acetate in Molecular Apocrine Breast CancerCompletedNCT01842321Phase 2
- BN83495 Phase I in Post-menopausal WomenCompletedNCT01840488Phase 1
- Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast CancerCompletedNCT01840306
- Breast Cancer Biomarker Sample Collection for the dtectDx Assay VerificationStatus unknownNCT01839045
- cMet CAR RNA T Cells Targeting Breast CancerCompletedNCT01837602Phase 1
- Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast CancerTerminatedNCT01837563
- Using Technology to Improve Physical Activity Levels Among Postmenopausal Women (The Active & Aware Study)CompletedNCT01837147Not applicable
- Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast CancerCompletedNCT01837095Phase 1
- Developing Plasma DNA as a Surrogate for Tumor Biopsy to Identify Tumor Genetic Alterations in Patients With Advanced Breast CancerTerminatedNCT01836640
- Trastuzumab & Pertuzumab Followed by T-DM1 in MBCCompletedNCT01835236Phase 2
- Web-based Screening and Tailored SupportCompletedNCT01834521Not applicable
- Clinical Value of 89Zr-trastuzumab PETCompletedNCT01832051Phase 2
- Breast Cancer Surveillance ConsortiumCompletedNCT01831778
- Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced AlopeciaStatus unknownNCT01831024Not applicable
- IST Neoadjuvant Abraxane in Newly Diagnosed Breast CancerStatus unknownNCT01830244Phase 2
- Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their CaregiversCompletedNCT01829984
- Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before MastectomyWithdrawnNCT01827969Not applicable
- Survivorship Care Planning in Improving the Quality of Life in Breast Cancer SurvivorsActive, not recruitingNCT01824745Not applicable
- Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer PatientsCompletedNCT01823549
- Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast CancerCompletedNCT01822314Phase 3
- Axillary Ultrasound With or Without Sentinel Lymph Node Biopsy in Detecting the Spread of Breast Cancer in Patients Receiving Breast Conservation TherapyTerminatedNCT01821768Not applicable
- Changes in Biomarkers of Cancer in Women With Breast Cancer and Without Evidence of Disease Who Were Given PhytoMed™CompletedNCT01819948Not applicable
- A Lifestyle Intervention for Breast Cancer SurvivorsCompletedNCT01819324Not applicable
- Ixabepilone and SBRT For Metastatic Breast CancerWithdrawnNCT01818999Phase 2
- A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT ProtocolCompletedNCT01817452Phase 2
- Epidemiological Analysis of Vitamin D and Breast Cancer Risk in Saudi Arabian WomenCompletedNCT01817231
- Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast CarcinomaTerminatedNCT01816555Phase 1
- Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by SurgeryCompletedNCT01816035Phase 1
- Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRGTerminatedNCT01815346Phase 1/2
- A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian CancerCompletedNCT01815294Phase 1
- Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast CancerCompletedNCT01815242Phase 2
- Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast CancerWithdrawnNCT01814865Phase 2
- Relationship Between Hypoxia and Endocrine Response in Human Breast CancerStatus unknownNCT01814449
- Improving Psychosocial Quality of Life in Women With Advanced Breast CancerCompletedNCT01811264Not applicable
- A Study to Assess Preference for Subcutaneous Trastuzumab Treatment in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Metastatic Breast Cancer Responding to First-Line Intravenous Trastuzumab for at Least 3 YearsCompletedNCT01810393Phase 3
- Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer PatientsTerminatedNCT01809171Phase 2/3
- A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast CancerCompletedNCT01808040Phase 1